TB-206-001

N/A

Report date: 2024/07/17 09:41:15
First In Class

Base Information

Drug NameTB-206-001
Drug Alias NameTB-206-001TB206-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Adenosine A2a receptor
TargetsAdenosine A2a receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTwist Bioscience HQ
China Registration ClassN/A

Develop Information

Active CompaniesTwist Bioscience HQ
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A